李秀楠 吴玉梅 刘爱蕙

    [摘要] 目的 探讨miR-27b在雌激素受体(ER)阳性的乳腺癌细胞上皮间质转化及他莫昔芬耐药中的调控机制。 方法 通过反转录实时定量PCR测定miR-27b的表达。用双荧光素酶报告和蛋白质印迹实验验证miR-27b对HMGB3的靶向调控作用。在他莫昔芬敏感(TamS)或耐药(TamR)的MCF-7细胞中过表达miR-27b或敲减HMGB3后测定细胞活力，分析上皮和间质标志物的表达，检测细胞侵袭力。 结果 TamR MCF-7细胞中miR-27b的水平约为TamS MCF-7细胞的20%。过表达miR-27b增加了4-羟基他莫昔芬(4-OHT)对TamR MCF-7细胞的活力抑制。TamS与TamR细胞在miR-27b过表达后，穿膜细胞数目均明显减少。在TamR MCF-7细胞中，转染miR-27b mimics增加了约3倍的E-cadherin表达，同时也降低了约70%的N-cadherin表达。miR-27b可以结合预测的HMGB3 3′非翻译区(UTR)结合位点并降低HMGB3在蛋白水平的表达。HMGB3敲减和miR-27b过表达具有类似的生物学功能。 结论 miR-27b可以通过抑制HMGB3的表达抑制乳腺癌细胞上皮间质转化并增强乳腺癌细胞他莫昔芬敏感性。

    [关鍵词] 雌激素受体；乳腺癌；miR-27b；他莫昔芬；HMGB3

    [中图分类号] R737.9 [文献标识码] A [文章编号] 1673-7210(2016)12(c)-0058-05

    [Abstract] Objective To investigate regulation mechanism of miR-27b in epithelial-to-mesenchymal transition and Tamoxifen sensitivity of ER positive breast cancer cells. Methods qRT-PCR was performed to detect miR-27b expression. Dual luciferase assay and Western blot assay were performed to detect the regulative effect of miR-27b on HMGB3 expression. Tamoxifen sensitive (TamS) and tamoxifen resistant (TamR) MCF-7 cells were transfected with miR-27b mimics or HMGB3 siRNA. Then cell viability ......